Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-08 | BeiGene, Ltd. | OYLER JOHN
(Chief Executive Officer) |
S | American Depositary Shares | D | 16175 | $229.25 - $236.37 | $3,756,086 |
| 2024-09-30 | BeiGene, Ltd. | Sharp Shalini
(Director) |
A | Ordinary Shares | A | 8151 | $0.00 - $0.00 | $0 |
| 2024-09-30 | BeiGene, Ltd. | Lee Chan Henry
(SVP, General Counsel) |
S | American Depositary Shares | D | 1202 | $237.10 - $237.10 | $284,994 |
| 2024-09-27 | BeiGene, Ltd. | Wang Lai
(Global Head of R&D) |
S | American Depositary Shares | D | 5000 | $220.35 - $220.35 | $1,101,774 |
| 2024-09-17 | BeiGene, Ltd. | Wu Xiaobin
(President, COO & GM China) |
S | American Depositary Shares | D | 5000 | $200.00 - $200.14 | $1,000,614 |
| 2024-08-12 | BeiGene, Ltd. | Wang Xiaodong
(Director) |
G | Ordinary Shares | D | 301457 | $0.00 - $0.00 | $0 |
| 2024-08-09 | BeiGene, Ltd. | Rosenberg Aaron
(Chief Financial Officer) |
A | Ordinary Shares | A | 118547 | $0.00 - $0.00 | $0 |
| 2024-07-30 | BeiGene, Ltd. | Lee Chan Henry
(SVP, General Counsel) |
S | American Depositary Shares | D | 834 | $160.57 - $160.57 | $133,915 |
| 2024-07-01 | BeiGene, Ltd. | Wang Julia Aijun
(Chief Financial Officer) |
S | American Depositary Shares | D | 472 | $143.90 - $143.90 | $67,918 |
| 2024-06-24 | BeiGene, Ltd. | Wang Julia Aijun
(Chief Financial Officer) |
S | American Depositary Shares | D | 899 | $155.66 - $155.66 | $139,938 |
| 2024-06-24 | BeiGene, Ltd. | Wang Lai
(Global Head of R&D) |
S | American Depositary Shares | D | 1064 | $159.80 - $161.10 | $170,029 |
| 2024-06-24 | BeiGene, Ltd. | Wu Xiaobin
(President, COO & GM China) |
S | American Depositary Shares | D | 1459 | $159.53 - $161.27 | $233,132 |
| 2024-06-17 | BeiGene, Ltd. | OYLER JOHN
(Chief Executive Officer) |
S | American Depositary Shares | D | 1281 | $158.53 - $159.91 | $204,123 |
| 2024-06-17 | BeiGene, Ltd. | Wang Julia Aijun
(Chief Financial Officer) |
S | American Depositary Shares | D | 916 | $158.24 - $159.74 | $145,675 |
| 2024-06-17 | BeiGene, Ltd. | Wang Lai
(Global Head of R&D) |
S | American Depositary Shares | D | 2341 | $153.75 - $159.90 | $368,159 |
| 2024-06-17 | BeiGene, Ltd. | Wu Xiaobin
(President, COO & GM China) |
S | American Depositary Shares | D | 3254 | $153.66 - $159.00 | $505,205 |
| 2024-06-17 | BeiGene, Ltd. | Lee Chan Henry
(SVP, General Counsel) |
S | American Depositary Shares | D | 439 | $158.20 - $159.74 | $69,953 |
| 2024-06-05 | BeiGene, Ltd. | Ball Titus B.
(Principal Accounting Officer) |
A | Ordinary Shares | A | 24427 | $0.00 - $0.00 | $0 |
| 2024-06-05 | BeiGene, Ltd. | Wu Xiaobin
(President, COO & GM China) |
A | Ordinary Shares | A | 253409 | $0.00 - $0.00 | $0 |
| 2024-06-05 | BeiGene, Ltd. | OYLER JOHN
(Chief Executive Officer) |
A | Ordinary Shares | A | 490464 | $0.00 - $0.00 | $0 |
| 2024-06-05 | BeiGene, Ltd. | Glazer Donald W.
(Director) |
A | Ordinary Shares | A | 16341 | $0.00 - $0.00 | $0 |
| 2024-06-05 | BeiGene, Ltd. | Riva Alessandro
(Director) |
A | Ordinary Shares | A | 16341 | $0.00 - $0.00 | $0 |
| 2024-06-05 | BeiGene, Ltd. | Wang Xiaodong
(Director) |
A | Ordinary Shares | A | 108992 | $0.00 - $0.00 | $0 |
| 2024-06-05 | BeiGene, Ltd. | Sanders Corazon (...
(Director) |
A | Ordinary Shares | A | 16341 | $0.00 - $0.00 | $0 |
| 2024-06-05 | BeiGene, Ltd. | Wang Julia Aijun
(Chief Financial Officer) |
A | Ordinary Shares | A | 136240 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |